Blood & Cancer-logo

Blood & Cancer

Health & Wellness Podcasts

Interview-style hematology/oncology podcast from MDedge Hematology-Oncology. The show is hosted by Dr. David Henry with Pearls from Dr. Ilana Yurkiewicz for clinical hematology and oncology health care professionals. The information in this podcast is provided for informational and educational purposes only.

Interview-style hematology/oncology podcast from MDedge Hematology-Oncology. The show is hosted by Dr. David Henry with Pearls from Dr. Ilana Yurkiewicz for clinical hematology and oncology health care professionals. The information in this podcast is provided for informational and educational purposes only.

Location:

United States

Description:

Interview-style hematology/oncology podcast from MDedge Hematology-Oncology. The show is hosted by Dr. David Henry with Pearls from Dr. Ilana Yurkiewicz for clinical hematology and oncology health care professionals. The information in this podcast is provided for informational and educational purposes only.

Language:

English

Contact:

2402212400


Episodes

How I treat multiple myeloma: Dr. Gustavo Fonseca talks triple-agent therapy, transplant, and treatment failure

8/6/2020
How does the community oncologist treat multiple myeloma? Gustavo A. Fonseca, MD, of Florida Cancer Specialists, shares his approach to myeloma treatment with host David H. Henry, MD. At the start of this episode, Dr. Fonseca and Dr. Henry discuss their love of podcasts, mentioning shows that have proven useful to them personally and professionally. The pair then move on to discuss hypothetical myeloma cases and advances in treatment. They cover triple-agent therapy, transplant, and...

Duration:00:32:35

News from EAU20, ISTH, and AACR's COVID-19 & Cancer meeting: Surgery in renal cell cancer, bevacizumab in HHT, and nosocomial COVID-19

8/4/2020
Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts This week in HemOnc News: Higher death rate seen in cancer patients with nosocomial COVID-19 Article: https://bit.ly/2XjRLDq Source: https://bit.ly/3goLGgF Robotic renal surgery bests open partial nephrectomy Article: https://bit.ly/2PhHS4M Source: https://bit.ly/3gqXXBd Large cohort study: Bevacizumab safe, effective for severe HHT bleeds Article: https://bit.ly/2XpuZdj Source: https://bit.ly/2BXHVQg For...

Duration:00:11:27

Beyond the lungs: How COVID-19 affects the blood, brain, gastrointestinal system, and other organ systems

7/30/2020
COVID-19 can have a negative impact on systems throughout the body, beyond just the lungs, according to a review published in Nature Medicine. Two authors of the review joined host David H. Henry, MD, to discuss their article, “Extrapulmonary manifestations of COVID-19.” Aakriti Gupta, MD, of Columbia University Irving Medical Center, and Kartik Sehgal, MD, of Dana Farber Cancer Institute, discussed: ACE2, the entry receptor for SARS-CoV-2Neurologic and gastrointestinal manifestations of...

Duration:00:37:50

RTL 03 - HemOnc News: New 'gold standard' for prostate cancer screening, pandemic could increase cancer deaths, genetic testing for early cancers

7/28/2020
Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts This week in HemOnc News: https://bit.ly/2CRaq2t https://bit.ly/3f18YHL https://bit.ly/2WZSIR3 https://bit.ly/3f18YHL https://bit.ly/2WZSIR3 https://bit.ly/39DoJUf https://bit.ly/3g6DiSF https://bit.ly/2WZSVnj https://bit.ly/30375Gp For more MDedge Podcasts, click this link: http://bit.ly/2CfnY52 Email the show: podcasts@mdedge.com Follow Dr. David Henry on Twitter @DavidHenryMD

Duration:00:13:31

Hematology|Oncology Journal Club 01 - All about breast cancer: Lumpectomy margins, partial vs whole breast irradiation, locoregional management after neoadjuvant chemo

7/23/2020
While relaxing on the Jersey Shore, host and MDedge Hematology/Oncology Editor-in-Chief, David Henry, MD, dove into the July 10, 2020, issue of the Journal of Clinical Oncology. In episode 82, we do the same. J Clin Oncol. 2020 Jul 10. 38(20). 2217-2361. (https://bit.ly/2ZQEJ27) You can follow along with the following articles: Lumpectomy Margins for Invasive Breast Cancer and Ductal Carcinoma in Situ: Current Guideline Recommendations, Their Implications, and Impact...

Duration:00:25:35

RTL 02 -- The latest news from MDedge Hematology/Oncology: MRI IDs significant prostate cancer, drug interactions to avoid in GI cancers, ctDNA clearance tracks with NSCLC survival, COVID symptoms persist

7/21/2020
The latest news from MDedge Hematology/Oncology: In this episode: https://bit.ly/3hgKT1h https://bit.ly/3fLOiEN https://bit.ly/39eHi0G https://bit.ly/3eJKm6o https://bit.ly/30uQQ3R https://bit.ly/3jq1L7J https://bit.ly/3eNREG0 https://bit.ly/2WFS3UW For more MDedge Podcasts go to https://mdedge.com/podcasts/ Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeHemOnc

Duration:00:13:18

Cancer and diet: Dr. Dawn Lemanne describes how fasting can suppress the immune system and lower IGF-1 and blood sugar levels

7/16/2020
Cancer patients often ask what they should eat, but it’s just as important to know when they should eat, according to Dawn Lemanne, MD, of Oregon Integrative Oncology, Ashland, and the University of Arizona, Tucson. Dr. Lemanne tells host David H. Henry, MD, how cancer patients may benefit from fasting. The pair discuss immune system suppression, insulinlike growth factor I (IGF-I), and blood glucose monitoring. Fasting and the immune system BMC Cancer. 2016 Jun 10;16:360 IGF-I...

Duration:00:24:27

Introducing Run the List: the latest hem onc news - Earlier lung screening doubles eligibility, lifestyle reduces breast cancer risk regardless of genetics, FDA approves MDS/CMML drug, COVID mask exemptions

7/14/2020
The latest news for hematology and oncology professionals. In this episode: USPSTF: Earlier lung cancer screening can double eligibility https://bit.ly/3fppiD7 https://bit.ly/2CvNRQt Lifestyle choices may reduce breast cancer risk regardless of genetics https://bit.ly/2ZrsWqN https://bit.ly/3etRLGx FDA approves oral therapy for myelodysplastic syndromes, CMML https://bit.ly/2WeUIVb :'Doc, Can I Get a Mask Exemption?' * Read the full commentary from Dr. Rizzo:...

Duration:00:12:17

Personal and professional impact of COVID-19 - diary of an oncologist and vacation on the shore

7/9/2020
Oncologist Don S. Dizon, MD, joins the podcast to discuss how the COVID-19 pandemic has affected him personally and professionally. Dr. Dizon is the director of women’s cancers at Lifespan Cancer Institute and director of medical oncology at Rhode Island Hospital, both in Providence. Dr. Dizon tells host David H. Henry, MD, how COVID-19 affected his patients, colleagues, and research as well as his personal life. Dr. Dizon chronicled some of these developments in a series of columns...

Duration:00:20:22

Patient anxiety, social support, optimism bias, and 'How long do I have left?': The best-of Dr. Ilana Yurkiewicz

7/2/2020
Ilana Yurkiewicz, MD, recorded dozens of Clinical Correlation segments for Blood & Cancer for more than a year. She also hosted a three-part series on difficult conversations that trainees have with their patients. In this episode, we revisit the best of Dr. Yurkiewicz. 'How long do I have left?' 02:59Anxiety 17:02Optimism Bias 20:21Social Support 23:51Family Dynamics 26:07 For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on...

Duration:00:30:33

EHA25: AML, myeloma, polycythemia vera, and COVID-19 with EHA President John Gribben

6/25/2020
EHA25 highlights: EHA President John Gribben talks AML, myeloma, polycythemia vera, and COVID-19 What were the late-breaking and practice-changing presentations at EHA25 Virtual? John Gribben, MD, DSc, president of the European Hematology Association, highlighted some of them in this podcast. Dr. Gribben and host David H. Henry, MD, discussed presentations on acute myeloid leukemia (AML), multiple myeloma, polycythemia vera (PV), and COVID-19. Videos of these and other presentations will...

Duration:00:28:51

Drugs FDA-approved for hematology / oncology in 2020: ‘Game-changing’ and ‘niche’ indications

6/18/2020
The Food and Drug Administration has approved dozens of drugs for new hematology/oncology indications this year. Host David Henry, MD, was joined by David Mintzer, MD, and other colleagues at Penn Medicine in Philadelphia – Justine Cohen, DO, and Ingrid Kohut, DO – to discuss some of these approvals. Dr. Mintzer reviewed: niraparib sacituzumab govitecan-hziy pembrolizumab mitomycin Details on all approvals are available on the FDA website. * * * Disclosures: Dr. Henry and all guests...

Duration:00:30:36

ASCO 2020: Practice-changing studies in breast, lung, colorectal, and other cancers

6/11/2020
What were the practice-changing studies presented at the 2020 ASCO Annual Meeting? Podcast host David H. Henry, MD, and retired oncologist Alan P. Lyss, MD, reviewed 12 studies and assessed their potential impact on treatment. Breast cancer Three-year follow-up of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2-blockade for HER2-positive breast cancer (TRAIN-2): A randomized phase III trial. (Abstract 501) KEYNOTE-355: Randomized, double-blind, phase...

Duration:00:42:25

Non–small cell lung cancer: How to choose the best therapy and reviewing the first virtual ASCO

6/4/2020
Jack West, MD, joins the podcast to discuss how he chooses first-line treatment in new patients with non–small cell lung cancer (NSCLC). Dr. West is an associate clinical professor in medical oncology at City of Hope Comprehensive Cancer Center in Duarte, Calif., and a thought leader in thoracic oncology. Dr. West also explores how the COVID-19 pandemic influences treatment approaches, the usefulness of liquid biopsy, and how he weighs the potentially higher risk for COVID-19 complications...

Duration:00:37:39

Would you choose oncology again? Plus, breast cancer research: HER2CLIMB, KEYNOTE 522, and DESTINY BREAST01 with Dr. Bill Gradishar

5/28/2020
David H. Henry, MD, answers the question, "Would you choose oncology again?" This question was asked of oncologists surveyed for the Medscape Oncologist Compensation Report 2020, and 96% of oncologists said they would still choose oncology as their specialty. Later, William J. Gradishar, MD, of Northwestern University in Chicago, joined Dr. Henry to discuss recent developments in breast cancer. Dr. Gradishar reviewed three trials presented at the 2019 San Antonio Breast Cancer Symposium...

Duration:00:29:28

VTE rate, "COVID toes," and Virchow's triad: What you need to know about COVID and coagulation

5/21/2020
Adam C. Cuker, MD, joins host David H. Henry, MD, to discuss recent findings regarding coagulation in COVID-19 patients. Both Dr. Cuker and Dr. Henry both practice at the Hospital of the University of Pennsylvania in Philadelphia. Dr. Cuker cited data suggesting at least 25%-30% of patients with COVID-19 develop venous thromboembolism (VTE), despite receiving prophylactic anticoagulation. Furthermore, COVID-19 patients have presented with “lots of different thrombotic manifestations,” he...

Duration:00:34:50

Curbsiders Host Dr. Matt Watto on being an internist in the COVID-19 pandemic

5/14/2020
In this episode, Matthew Watto, MD, an internist at Pennsylvania Hospital in Philadelphia, tells host David H. Henry, MD, also of Pennsylvania Hospital, how the COVID-19 pandemic has affected him personally and professionally. Dr. Watto recounts how COVID-19 has impacted patient volume, shifts, teaching, and interactions between patients and staff. Dr. Watto also discusses his internal medicine podcast, The Curbsiders, which, he says, provides listeners with “clinical pearls,...

Duration:00:32:35

Treating genitourinary malignancies in the COVID-19 era

5/7/2020
How should oncologists be treating genitourinary malignancies during the COVID-19 pandemic? Aly-Khan A. Lalani, MD, of McMaster University in Hamilton, Ontario, and colleagues recently published recommendations that help answer that question (Can Urol Assoc J. 2020 May;14[5]:e154-8). In this episode, Dr. Lalani reviews some of these recommendations with podcast host David H. Henry, MD, of Pennsylvania Hospital in Philadelphia. The pair discuss when and how to use androgen receptor...

Duration:00:36:15

The first virtual ASCO meeting; plus Part 2 of tech tools for docs

4/30/2020
The American Society of Clinical Oncology is gearing up for its first-ever virtual meeting at the end of May 2020. ASCO’s president Howard A. “Skip” Burris, III, MD, joins David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to explain how the virtual meeting will work, from releasing research to earning continuing medical education credits. Dr. Burris also explores how the society is responding to COVID-19. Later in the podcast, Bernard A. Mason, MD, an oncologist with Pennsylvania...

Duration:00:39:16

Treating colorectal cancer in the COVID-19 era

4/23/2020
Oncologists are now weighing the benefits of treating cancer patients against the risk of exposing them to SARS-CoV-2. David Kerr, MD, DSc, of University of Oxford (England) talks with podcast host David H. Henry, MD, of Pennsylvania Hospital in Philadelphia, about how to treat colorectal cancer patients in the COVID-19 era. Dr. Kerr cowrote an article on MDedge Hematology/Oncology that outlined recommendations for treating colorectal cancer patients during the pandemic. In this episode,...

Duration:00:41:24